INTRODUCTION
The renin angiotensin aldosterone system (RAAS) plays a pivotal role in renal development, the control of blood pressure and fluid homeostasis. Inappropriate activation of the RAAS in adult mammals contributes to the development of hypertension, cardiac hypertrophy, and heart failure. The first and rate-limiting step in the initiation of RAAS is catalyzed by the aspartyl protease Renin, which is predominantly produced in the kidney. The mechanisms underlying renin production have been investigated in the developing kidney as well as during pathological conditions in adult animals. In the developing kidney, lineage tracing studies using the Ren1 promoter have shown that renin producing cells derive from mesenchymal precursors at embryonic day (E)11.5 (12, 22, 28) . These renin precursors are positive for the transcription factor Foxd1 (12, 19, 26) .
The expression of renin in the embryo is detectable by E14.5 (17) , and increases thereafter, such that by embryonic day 15.5 renin is present in the renal artery, interlobar arteries, and the arcuate arteries of the metanephric kidney (23) . After birth, renin expressing cells become restricted to the terminal portion of the juxtaglomerular (JG) afferent arteriole. In adults, conditions such as chronic ischemia, prolonged adrenergic activation, and sodium depletion perturb blood pressure homeostasis and increase the number of renin expressing cells along the afferent arteriole, the kidney interstitium, and inside the glomerulus recapitulating the embryonic distribution of renin expression (9) (10) (11) .
This process of JG cell recruitment occurs via several cellular mechanisms (15, 20, 27) .
One mechanism involves dedifferentiation and re-expression of renin by renal smooth muscle cells (SMC) along the arteriole (15, 27) . An alternative mechanism is the differentiation of pericytes (3, 23, 26) and adult renal mesenchymal stromal cells (MSC) into renin expressing cells (29).
The mechanisms regulating renin expression remain elusive. Various studies have stressed the importance of transcriptional mechanisms in the control of renin expression.
Renal smooth muscle cells along the afferent arteriole produce renin and participate in JG cell expansion, and in these cells the transcription factor RBP-J plays a key role in renin expression and the JG cell identity (12). Moreover, transcription factors such as CRAB/CREM, HOX/PBX, and LXRα bind to the renin promoter where they exert positive and negative control over renin expression in vitro (4, 14) . Also, a recently published study show that super-enhancers are involved to maintain renin-expressing cell identity and memory to preserve multi-system homeostasis (22) .
Here we show evidence that the transcription factor Sox6 critically modulates renin expression both in vitro and in vivo. Sox6, which belongs to the Sry (sex determining region Y) subfamily Sox D proteins (5, 13, 18) , activates or represses gene transcription through association with multiple transcription factors (18) . Gene centric arrays and genome wide association studies have shown a strong association of Sox6 with hypertension (7, 8, 16, 21) . Sox6 is expressed and has biding site in the renin promoter within the super-enhancer region (22) . In vitro, we found that Sox6 is necessary for the c-AMP-mediated induction of renin expression in renal tissue specific stem-progenitor or mesenchymal stromal cells. In adult mice, JG cell expansion stimulated by a sodium restricted diet and furosemide induces Sox6 expression. Sox6 co-localizes with renin cells; as well as renal MSCs and smooth muscle cells in the afferent arteriole. Transcript profiling. Renal MSCs were isolated from adult C57BL/6 Ren1c YFP mice described above. Juxtaglomerular cells were isolated from adult C57BL/6 Ren1c YFP mice by FACS using YFP expression as a surrogate for renin expression.
Isolation and culture of renal mesenchymal stromal cells (MSCs). Renal MSC isolation
and culture were carried out as previously reported 14 . Renal MSCs were differentiated with 3-Isobutyl-1-methylxanthine (IBMX -100 µM) and Forskolin (10 µM) (I&F) as described previously 14, 25 .
Induction of JG cell expansion in vivo. JG cell expansion in vivo was induced by low salt diet plus furosemide as described before 14 .
Kidney Immunohistochemistry (IHC). IHC staining of kidney sections was performed as previously described 28 .
Flow cytometry. Single cell suspension obtained as before 28 . Western blotting was performed as previously described (25) .
Renin and
In situ hybridization: Localization of Sox6 transcription factor and renin mRNA synthesis was studied using the RNAscope® 2.5 HD duplex detection assay (Advanced Cell diagnostics, ACD, Newark, CA, USA) for in situ hybridization technology following manufacture's protocols.
Statistics. All statistical analysis was performed using GraphPad Prism 7.03. A t-test was performed for experiments containing two conditions. One-way or two-way ANOVA was used for experiments with three or more conditions followed by Bonferroni post-hoc tests for comparisons between individual groups. A P-value equal or less than 0.05 was considered significant. 
RESULTS

Identification of
DISCUSSION
Renin is the rate-limiting enzyme to produce ang II, and thus plays a pivotal role in the RAAS system. RAAS activity is essential for water and electrolytes balance and blood pressure control. RAAS exerts its blood pressure control through plasma circulating renin.
While renin is produced in different tissues, the predominant site of production is the kidney, where it is produced and stored by Juxtaglomerular cells (1) . Control of renin expression and secretion is of great importance for human health. Renin expression and secretion is carefully coordinated by several proteins that work in a harmonized manner maintaining blood pressure and fluid homeostasis.
In this study, we demonstrate that Sox6 has a new function in the control of renin expression. Under pathological conditions, JG cells arise from several cellular sources.
Previously, we reported that resident renal mesenchymal stromal cells (MSC) play a role in JG cell expansion and that a subset of these MSCs differentiates into renin expressing cells (29). Other studies have stressed the importance of arteriolar smooth muscle cells (SMCs) in afferent arteriole (9, 22, 27) . In our study, we show that not only does Sox6 colocalize with renin, but it also co-localizes with markers of both renal MSCs and SMCs during JG cell expansion. Likewise, flow cytometry quantification of renin positive cells showed that Sox6 specific ablation in renin expressing cells inhibits the increase in renin+ cells during JG cell expansion. Moreover, we found that Sox6 controls the expression of renin in MSCs after cAMP stimulus in vitro.
Gene centric array and genome-wide association (GWAS) studies have identified an association between hypertension in various ethnic groups and single nucleotide polymorphisms (SNPs) in the Sox6 gene (7, 8, 16, 21) . It is currently unknown how these SNPs affect Sox6 function. In the light of our study, it is possible that these SNPs affect the ability of Sox6 control over renin expression.
The second messenger cAMP is important for renin expression. The renin promoter contains cAMP responsive elements in the proximal and distal promoters where cAMP responsive transcription factors bind promoting renin expression (4) . In silico analysis of renin promoter shows that there is a Sox6 binding site in the proximal promoter, and not within any of the cAMP responsive elements. However, Sox6 expression itself is stimulated by cAMP and its promoter contains binding sites for cAMP responsive transcription factor such as ATF1, ATF2, and ATF7 which may bind and stimulate Sox6 expression. Future experiments defining the role of cAMP in Sox6 expression and its relationship to renin expression will be of interest.
In vivo, renin mRNA expression increased after 10 days of low sodium diet and furosemide. Sox6 specific ablation in renin expressing cells inhibited the increase in renin protein expression and mRNA expression observed in wild type mice during JG cell expansion.
Taken together, our findings indicate that Sox6 has a previously undefined role in modulating renin expression at baseline and in response to sodium and volume deprivation. Given this critical function, Sox6 might also be a therapeutic target for the treatment of hypertension.
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